Navigation Links
Thoratec Schedules First Quarter 2008 Conference Call, Webcast
Date:4/25/2008

PLEASANTON, Calif., April 25 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first fiscal quarter of 2008 on Thursday, May 1.

The company will hold a conference call to discuss its financial results and operating activities to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Thursday, May 1, hosted by Gary F. Burbach, president and chief executive officer, and David Smith, executive vice president and chief financial officer.

The teleconference can be accessed by calling (913) 981-5526, passcode 1224200. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will also be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=95989&eventID=1823004 or at http://www.thoratec.com.

A replay of the conference call will be available through Thursday, May 8, via http:///www.thoratec.com or by telephone at (719) 457-0820, passcode 1224200.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com


'/>"/>
SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
2. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
3. Thoratecs ITC Division Receives FDA Warning Letter
4. Thoratec Schedules Third Quarter Conference Call, Webcast
5. The Advisory Board Company Schedules Fourth Quarter Investor Conference Call for May 8, 2008
6. The Ensign Group Schedules 2008 First Quarter Earnings Call for Thursday, May 8, 2008
7. AMICAS Schedules First Quarter 2008 Earnings Call
8. Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast
9. LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
10. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
11. MSA Schedules First Quarter Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... It has just been announced ... for five events throughout the month of May. , Uldrich is the author of ... outlets. He also frequently appears on the Science Channel’s FutureScape and Discovery Channel’s Inside ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... Issue 1 of Patient Experience Journal (PXJ), an international, open access, peer-reviewed ... With almost half the issue representing international (non-US) based authors, the third volume ...
(Date:5/2/2016)... ... 02, 2016 , ... Beanfields, PBC, makers of Beanfields Bean ... students at University of Colorado in Boulder to create new advertising campaigns. , ... the School of Journalism, who selected Beanfields as the brand on which to ...
(Date:5/2/2016)... ... 2016 , ... Amica Life Insurance Company has unveiled ... various life stages. , The site launched on April 1, and it has ... to the times when life insurance matters most. , “Through our research, we ...
(Date:5/2/2016)... ... 2016 , ... The National Resident Matching Program® (NRMP®) has ... Match”), the system through which U.S. and international medical school students and graduates ... placed in the 2016 Match, and 29,572 were filled when the matching algorithm ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- TapImmune,Inc. (TPIV), a clinical-stage immune-oncology ... immunotherapeutics and vaccines for the treatment of cancer & metastatic ... Annual Growth Capital Expo to be held on May ... Palace in Las Vegas, Nevada.  The Company presentation will ... by Dr. John N. Bonfiglio a TapImmune ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology: